Clinical trial
Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca…
NCT00300768 · Medicines Development for Global Health, Other · Completed
Key facts
| NCT number | NCT00300768 |
|---|---|
| Title | Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection |
| Official title | A Randomized, Single-Ascending Dose, Ivermectin-Controlled, Double-Blind, Safety, Tolerability, Pharmacokinetic, and Efficacy Study Of Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection |
| Lead sponsor | Medicines Development for Global Health, Other |
| Collaborators | World Health Organization |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Onchocerciasis |
| Intervention type | Drug |
| Interventions | 2 mg moxidectin, ivermectin 150 mcg/kg, 4 mg moxidectin, 8 mg moxidectin |
| Enrollment | 172 |
| Start date | Sep 6, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 29, 2009 |
| First posted | Mar 9, 2006 |
| Last update posted | Dec 15, 2022 |
| Countries | Ghana |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: